Rapid Therapeutic Science Laboratories, Inc.
RTSL
$0.0074
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 226.09% | 112.11% | 104.03% | 61.07% | 93.13% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -1,150.91% | 396.36% | 781.82% |
| Total Amortization of Deferred Charges | -92.59% | -95.17% | -81.14% | -40.00% | -- |
| Total Other Non-Cash Items | 88.56% | -459.48% | -244.68% | 21.41% | -- |
| Change in Net Operating Assets | -146.88% | -47.20% | -475.44% | 312.33% | 25.85% |
| Cash from Operations | -111.20% | 94.02% | 36.22% | 76.73% | 115.45% |
| Capital Expenditure | -- | -- | 279.93% | 100.00% | -1,498.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 279.93% | 100.00% | -1,498.00% |
| Total Debt Issued | -109.01% | -85.46% | -- | -93.23% | 49.20% |
| Total Debt Repaid | 63.20% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.43% | -89.67% | -- | -96.79% | 9.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.44% | 111.03% | 100.00% | -112.87% | 157.77% |